Using the CNBC RQ 50 measure for R&D productivity, we've identified an elite group of companies that merit election to an R&D hall of fame.» Read More
What follows is a roundup of corporate earnings reports for Tuesday, April 20.
The Dow erased its early gains Tuesday as IBM and Goldman Sachs fell despite solid earnings reports from both companies.
U.S. stock index futures gained ground after Goldman Sachs reported quarterly earnings that easily beat estimates even as the company comes under intensified fire for its trading practices.
Cramer makes the call on viewers' favorite stocks.
US Stocks rose for the third consecutive week, with the Dow halting its eight-session winning streak on Friday.
Following are some moves you might have missed. Find out why shares of Dolan Media and Aluminum Corp Of China popped while Shaw Group and Forest Labs dropped.
Most European indices are down 1 percent or more this morning, as concerns about Greece continues. The spread on the 10-year Greek to comparable German bonds widened to 440 basis points. The dollar is up again. Also: March retail sales were even better than analyst expectations, despite the fact that analysts were aggressively raising numbers going into the end of the month.
What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.
Companies are increasingly sharing their record cash hoard with investors, and that trend should accelerate with a new wave of increased dividends and buybacks this quarter, according to a report from an investment bank.
It looks like Ben will get the votes necessary for another four year term, but at what cost? Harry Reid, he of the Senator Ben Nelson of Nebraska deal to sell 49 states down the Medicaid road to get one Senator's vote, alleged to have extracted a promise from Bernanke that Ben take additional steps to increase the flow of credit to the middle class.
Stocks rose to fresh 15-month highs Tuesday, led by health-care stocks as a key Senate-seat vote in Massachusetts today could change the course of health-care reform. Citigroup bounced back after an initial dip on disappointing results.
Stocks rallied Tuesday, led by health-care stocks as a key Senate-seat vote in Massachusetts today could change the course of health-care reform. Citigroup bounced back after an initial dip on disappointing results.
Stocks pushed higher, buoyed by gains in drug and chip stocks. Citigroup bounced back after an initial dip on disappointing results.
It's early, but sell the news is the mantra so far for earnings. Stock are futures down, bonds and the dollar are up this morning. The S&P 500 recorded its largest down day in almost a month last Thursday, despite a good report from Intel. In-line (Citi) or even slightly better than expected earnings (Intel) may not be good enough...
Wall Street investors returned from a long weekend undecided about how to trade, with stock index futures pointing to little change at the open. But earnings from Citigroup could dictate direction from the opening bell.
What follows is a roundup of corporate earnings reports for Tuesday, Jan. 19.
The Bureau of Labor Statistics doesn't release its official jobs report until Friday but there is lots of preamble.
We are putting cash back to work, said Ron Muhlenkamp, portfolio manager at The Muhlenkamp Fund, and Jeff Mortimer, CIO of Charles Schwab Investment Management.
The slumping economy negatively impacted many smaller companies that reported earnings on Tuesday. The following are some firms that reported earnings before the opening bell:
Markets are bracing for a landslide of earnings news Tuesday and more focus on the Treasury's bank bailout plans.